Acne Vulgaris-Solution

The recent scientific findings about the role of Propionibacterium acnes (P. acnes) in acne vulgaris have opened the path for the development of a new, highly specific and efficacious acne therapy. Our therapeutic product is designed to support the human immune system in controlling the growth of P. acnes on the skin and prevent it from damaging the cellular lining of the pores. Our intention is not just to provide a more effective treatment of acne, but also to prevent its formation in the first place, thereby avoiding any potential skin damage (scarring). Therefore, both therapeutic and prophylactic immunotherapy may be possible.